Due to the rise in medical research activities and the presence of prominent technology suppliers, the APAC market is expected to archive the fastest growth in the near future. Next-generation sequencing (NGS) is a high-throughput technology that may be used to learn about any organism at the transcriptomic, genomic, or epigenetic level.
The pandemic has had a positive influence on the market. To study the virus's structure, the genomic sequence of its etiological agent had to be rebuilt right away. Furthermore, the testing procedure for virus-infected persons has become easier owing to NGS, allowing healthcare experts to create tailored medications for their treatment.
- Twist Bioscience Corporation and C2I Genomics Inc., a cancer intelligence firm, confirmed a partnership in February 2022 to create whole-genome cancer reference materials.
- Agilent Technologies Inc. purchased Resolution Bioscience Inc., a company involved in the commercialization and development of NGS solutions, in April 2021, to expand its precision oncology testing services to patients worldwide.
- The North American NGS sample preparation market accounts for the biggest revenue share, and it is predicted to grow at a fast pace during the forecast period. This is due to the increasing RD in NGS and its potential applications in clinical practices.
- The market will also grow due to the significant expansion of the life sciences industry. The demand for NGS samples is driven by the industry's high adoption of improved technologies, growth in developing countries, and increase in scientific and technological skills.
- In 2021, the DNA sequencing category held the largest market share, and this trend is projected to continue in the future. Because DNA sequencing is more cost-effective and faster than manual sequencing, it is the most-common use of NGS samples.
In 2021, the consumables category dominated the market, and it is expected to continue its dominance in the future. The growing demand for testing and associated equipment and components, as well as the pertinent research in DNA, RNA, and whole-genome sequencing, supports the demand for consumables. Low-volume, kits, microplates, reagents, storage plates, and pipettes are some of the important consumables involved in sample preparation.
To gain a competitive advantage, key players in the NGS sample preparation market are forming alliances and acquiring companies. These players are Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Oxford Nanopore Technologies plc, New England Biolabs Inc., Integrated DNA Technologies Inc., Illumina Inc., Pacific Biosciences of California Inc., and Beckman Coulter Inc.
Explore the Growing NGS Sample Preparation Market
